Literature DB >> 22293787

[Gastrointestinal mixed adenoneuroendocrine carcinomas. An attempt at classification of mixed cancers].

S Reu1, J Neumann, T Kirchner.   

Abstract

Mixed adenoneuroendocrine carcinomas (MANECs) are a challenge for the diagnostics and the concept of a histogenetic tumor typing. They are classified into three malignant subgroups: high grade malignant MANECs combine an adenoma or adenocarcinoma with a small cell or large cell neuroendocrine carcinoma, intermediate grade malignant MANECs consist of a neuroendocrine tumor (NET grade 1 or 2), often a globlet cell carcinoid and a poorly differentiated adenocarcinoma or diffuse carcinoma of signet ring cell type. The prototype of a low grade malignant MANEC is the globlet cell carcinoid. Molecular analysis indicates a common clonal origin of the different components in MANECs. The prognosis is determined by the most aggressive tumor component. The pathogenesis of MANECs is apparently a sequence of increasing malignant transformation which leads either from an adenoma/adenocarcinoma to a small or large cell neuroendocrine carcinoma or from a neuroendocrine tumor (NET), often a globlet cell carcinoid to a poorly differentiated adenocarcinoma or a diffuse carcinoma of signet ring cell type.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22293787     DOI: 10.1007/s00292-011-1552-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  16 in total

1.  Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.

Authors:  Timothy D Jones; Kevin M Kernek; Ximing J Yang; Antonio Lopez-Beltran; Gregory T MacLennan; John N Eble; Haiqun Lin; Chong-Xian Pan; Maria Tretiakova; Lee Ann Baldridge; Liang Cheng
Journal:  Hum Pathol       Date:  2005-07       Impact factor: 3.466

2.  Colorectal glandular-neuroendocrine mixed tumor: pathologic spectrum and clinical implications.

Authors:  Yunru Li; Annie Yau; David Schaeffer; Anthony Magliocco; Xianyong Gui; Stefan Urbanski; Ranjit Waghray; David Owen; Zu-hua Gao
Journal:  Am J Surg Pathol       Date:  2011-03       Impact factor: 6.394

3.  Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms.

Authors:  Stefano La Rosa; Frediano Inzani; Alessandro Vanoli; Catherine Klersy; Linda Dainese; Guido Rindi; Carlo Capella; Cesare Bordi; Enrico Solcia
Journal:  Hum Pathol       Date:  2011-05-04       Impact factor: 3.466

4.  Genetic evidence for the multi-step progression of mixed glandular-neuroendocrine gastric carcinomas.

Authors:  Kyoung-Mee Kim; Min-Joo Kim; Bo-Kyoung Cho; Sang-Wook Choi; Mun-Gan Rhyu
Journal:  Virchows Arch       Date:  2002-01       Impact factor: 4.064

5.  Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.

Authors:  Mirela Stancu; Tsung-Teh Wu; Charita Wallace; Patrick S Houlihan; Stanley R Hamilton; Asif Rashid
Journal:  Mod Pathol       Date:  2003-12       Impact factor: 7.842

6.  Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.

Authors:  Dipen M Maru; Hema Khurana; Asif Rashid; Arlene M Correa; Sharmila Anandasabapathy; Sunil Krishnan; Ritsuko Komaki; Jaffer A Ajani; Stephen G Swisher; Wayne L Hofstetter
Journal:  Am J Surg Pathol       Date:  2008-09       Impact factor: 6.394

7.  Primary mixed adenocarcinoma and small cell carcinoma of the appendix: a clinicopathologic, immunohistochemical, and molecular study of a hitherto unreported tumor.

Authors:  Giulio Rossi; Federica Bertolini; Giuliana Sartori; Nazzarena Bigiani; Alberto Cavazza; Moira Foroni; Riccardo Valli; Guido Rindi; Carmela De Gaetani; Gabriele Luppi
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

Review 8.  Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas.

Authors:  K Lewin
Journal:  Am J Surg Pathol       Date:  1987       Impact factor: 6.394

9.  Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix.

Authors:  Laura H Tang; Jinru Shia; Robert A Soslow; Deepti Dhall; W Douglas Wong; Eileen O'Reilly; Jing Qin; Philip Paty; Martin R Weiser; Jose Guillem; Larissa Temple; Leslie H Sobin; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2008-10       Impact factor: 6.394

10.  Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases.

Authors:  Jing-Ping Yun; Mei-Fang Zhang; Jin-Hui Hou; Qiu-Hong Tian; Jia Fu; Xiao-Man Liang; Qiu-Liang Wu; Tie-Hua Rong
Journal:  BMC Cancer       Date:  2007-03-03       Impact factor: 4.430

View more
  6 in total

1.  [Neuroendocrine tumors].

Authors:  W Saeger
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

Review 2.  [Neoplasms of the disseminated neuroendocrine cell system of the gastrointestinal tract].

Authors:  G Klöppel
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

3.  Prognostic impact of neuroendocrine differentiation in high-grade serous ovarian carcinoma.

Authors:  E T Taube; C Denkert; K Pietzner; M Dietel; J Sehouli; S Darb-Esfahani
Journal:  Virchows Arch       Date:  2014-12-19       Impact factor: 4.064

Review 4.  [Gastroenteropancreatic neuroendocrine neoplasms. Role of biopsies].

Authors:  F Bergmann
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

5.  Secondary Nasopharyngeal Mixed Adenoneuroendocrine Carcinoma After Radical Radiotherapy for Nasopharyngeal Carcinoma: A Rare Case and Literature Review.

Authors:  Donglan Huang; Chunyue Huang; Hongmei Wang; Lizhen He; Jian Zhang; Xi Zhong; Ziqian Guo; Yawei Yuan; Weijun Zhang
Journal:  Onco Targets Ther       Date:  2021-02-25       Impact factor: 4.147

6.  Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity.

Authors:  Christine Woischke; Peter Jung; Andreas Jung; Jörg Kumbrink; Sibylle Eisenlohr; Christoph Josef Auernhammer; Michael Vieth; Thomas Kirchner; Jens Neumann
Journal:  J Pathol Clin Res       Date:  2020-11-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.